Understanding the Metabolism-immunity Duality of a Glycolytic Inhibitor through Metabolic Imaging to Improve Cancer Immunotherapy in Mice
Published: 2 January 2024| Version 2 | DOI: 10.17632/wfnw7kh6s9.2
Contributor:Yu Sheng Guo
Our research offers novel perspectives on the application of the glycolytic inhibitor 2DG and emphasizes the significance of radiation-free and non-invasive comprehensive evaluation of glycolysis in the current immunotherapy era.
Huazhong University of Science and Technology